The new neuromuscular blocker, Org NC 45 was applied to the toad sartorius nerve-muscle preparation. Measurement of the variance ratio of end-plate potentials recorded by microelectrodes demonstrated that in concentrations greater than that required to block myoneural transmission, Org NC 45 reduced the quantal release of acetylcholine.
and perfused with normal toad Ringer's solution containing respectively 1·2, 2 and 4 mg/l Org NC 45, in random order. The method of intracellular recording of the end-plate potential is well known and described in full elsewhere. 6 ,7 One hundred or more end-plate potentials generated by supramaximal indirect stimulation of 50 x 10-6 sec duration, at 1 Hz frequency were recorded from the screen of a storage oscilloscope and quantal content was calculated from the variance ratio. The experiments were performed at 23 ± 1 °C and Student's t for paired values was used to test the results for significance.
RESULTS
Org NC 45 did not affect the resting potential of the cells. The amplitude of the end-plate potential was reduced in a concentration dependent manner, as shown in Table 1 . The regression line: EPP = 1·96 -2·36 log [Org NC 45] fitted to the data had a correlation coefficient (Pearson) of 0.788. The differences in EPP between the three groups were significant (p < 0.001). Cell no.
End-plate potential Quantal content was also reduced in a dose dependent manner as shown in Figure 1 and Table 2 . The relation between quantal content (m) and the logarithm of the concentration of Org Ne 45 also appeared with a correlation coefficient of 0.649 ( Figure 1 ). m = 177 -224 log [Org Ne 45] The differences in quantal content between 1·2 and 2 mg/l treated preparations and the 1·2 and 4 mg/l were significant (p < 0.01). The difference between 2 and 4 mg/l treated preparations was significant (p -<-" 0.05).
DISCUSSION
The efficacy and clinical usefulness of OIg Ne 45 has already been well demonstrated, lA although its mode of action has not been examined in depth. Neuromuscular blocking drugs by definition exert their action at some intermediate step between the arrival of the nerve action potential at the motor nerve terminal and the generation of the muscle action potential. The steps can involve interference with transmitter release, as in the case of amino-glycoside antibiotics. 7 • R Drugs can block the postsynaptic receptors by competitive antagonism (e.g. d-tubocurarine) or other means. It has been suggested 9 • 1O (and denied ll ), that d-tubocurarine reduces acetylcholine (quantal) release as well as occupying postsynaptic receptors. 12 For that reason, it was decided to test this new and promising neuromuscular blocker for possible pre-synaptic action.
In order to determine the mean number of quanta of acetylcholine released by an action potential, movement of the muscle fibres must be prevented, without interference with the neural end-plate potential. This can be done by several methods, each having its advantages and disadvantages. For the screening experiments reported in this paper, a simple Anae.Sfhnw and Intensive Cure, Vo/. X, No. 2, lvtay, 1982 way was chosen. Enough of the blocking drug was added to the perfusing solution to stop movement. The end-plate potential, although sub-threshold, was still easily recordable. Estimates of quantal content were made at three drug concentrations, all greater than that necessary to prevent movement of the preparation.
The results demonstrated that at the concentrations tested, which were all above the "blocking" concentration Org NC 45 reduces the mean quantal content. By arranging the treatments in random order it could be shown that this action is reversible. Whether such action is present at lower concentrations is the subject of further studies. In practical terms, however, the presence of a presynaptic effect would not be in any way undesirable in a neuromuscular blocking drug, nor would it require any modification of customary techniques of relaxant anaesthesia.
